In addition, data from NAFLD patients and HFD-fed mice both showed that miR181b targets SIRT1 to regulate hepatic steatosis, a finding that was also confirmed in vitro [69]. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.